EEErol Eroglu

Erol Eroglu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Erol Eroglu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Machine Learning-Based Classification of Pairwise Selectivity Among Human Carbonic Anhydrase I, II, IX, and XII Isoenzymes

    by Elif Gozde Hacisuleyman, Ahmet Kayraldiz, Erol Eroglu

    Human carbonic anhydrase (hCA) isoenzymes participate in essential pH-regulatory processes, but conservation of their catalytic sites makes selective inhibition difficult. We developed a direct pairwise machine learning framework for selectivity among hCA I, II, IX, and XII using curated Ki data from ChEMBL. Compounds entered a binary task only when one isoenzyme was strongly inhibited (Ki ≤ 200 nM) and the paired isoenzyme was weakly inhibited (Ki > 800 nM). A provenance-conservative STRICT analysis and a BROAD sensitivity analysis were evaluated under train-only split selection, hyperparameter optimization, and a globally locked outer-test protocol. The highest observed held-out performance was obtained for CA II/CA XII (MCC = 0.748) and CA IX/CA XII (MCC = 0.718), whereas CA II/CA IX was intermediate (MCC = 0.459) and CA-I-containing tasks were generally more difficult. Because the highest point estimates arose from relatively small test cohorts, these findings should be regarded as promising and require independent external or prospective validation. All six STRICT models exceeded 100 randomized-label controls (empirical p = 1/101 ≈ 0.0099, the resolution floor for 100 permutations). Applicability domain and SHAP analyses indicated pair-specific signals compatible with known isoenzyme-dependent active-site differences. Overall, the framework prioritizes interpretable hCA selectivity hypotheses while explicitly defining current uncertainty and validation limits.

  • Open Access

    Angiotensin 1-7 Modulates the Dynamics and Activation of the Proto-oncogene Mas Receptor

    by Ekrem Yasar, Segun Dogru, Erol Eroglu, Nazmi Yaras

    The proto-oncogene Mas receptor (MasR, UniProt ID: P04201) is a class-A (orphan-type) G protein-coupled receptor (GPCR) that mediates the protective effects of Angiotensin 1-7 (Ang 1-7) within the renin–angiotensin system (RAS). Despite its therapeutic relevance, the molecular mechanisms underlying MasR activation by Ang 1-7 remain elusive due to the lack of experimental structural data. In this study, we performed 1-microsecond all-atom molecular dynamics (MD) simulations of AlphaFold-modeled active and inactive MasR conformations, with and without Ang 1-7, to characterize ligand-induced conformational dynamics. Ang 1-7 binding led to increased interaction stability in the active state, reflected by higher occupancy of hydrogen bonds, salt bridges, and hydrophobic contacts. Structural analyses revealed reduced RMSD/RMSF values and stabilization of key transmembrane (TM) helices and the NPxxY micro-switch. TM distance and dihedral analyses indicated partial TM6 displacement and time-dependent NPxxY reorganization. Network-based metrics including betweenness centrality and shortest path length highlighted the emergence of state-specific communication hubs, while PCA, correlation and communication propensity analyses revealed enhanced conformational diversity and selective inter-residue signaling in the ligand-bound state. Molecular mechanics Poisson–Boltzmann surface area (MM/PBSA) calculations showed favorable binding energetics in the active state (ΔG Bind = –13.99 kcal/mol). These results demonstrate that Ang 1-7 acts as a partial agonist of MasR by stabilizing the inactive conformation while inducing limited activation features in the active state through non-canonical micro-switch dynamics. This work advances structural insights into MasR regulation and provides a foundation for therapeutic targeting of the ACE2/Ang 1-7/MasR axis.

  • Open Access

    Ligand Binding Effects on Activation of Type-2 Angiotensin II Receptor

    by Ekrem Yasar, Segun Dogru, Erol Eroglu, Nazmi Yaras

    The Angiotensin II type-2 receptor (AGTR2) is a G-protein coupled receptor (GPCR) in the Renin-Angiotensin System (RAS), mediating essential roles in cardiovascular regulation. Overactivation of AGTR2 causes to cardiovascular pathologies, ranging from hypertension to cancer. Despite its physiological importance, the molecular mechanisms driving AGTR2 activation remain poorly understood. Using long-timescale molecular dynamics (MD) simulations, we investigated the ligand binding effects of Angiotensin II (Ang II) and Angiotensin 1-7 (Ang 1-7) on AGTR2 in inactive and active states. Our results demonstrate that Ang II stabilizes the active-state of AGTR2 by reducing fluctuations in TM6 and Helix8, thereby promoting receptor activation. In contrast, Ang 1-7 modulates the inactive-state by enhancing flexibility in intracellular loops and Helix8, suggesting may a preparatory role for receptor activation. Key interactions, including hydrogen bonds (e.g., PRO7-THR1253.33 for Ang 1-7 and PHE8-LYS2155.42 for Ang II), salt bridges (e.g., ARG2-ASP2796.58 and ARG2-ASP2977.32), and hydrophobic contacts (e.g., TRP1002.60, MET1283.36), were identified as critical for receptor stability and ligand-specific dynamics. Analyses of conserved micro-switch motifs (CWxP, PIF, E/DRY, NPxxY) and intracellular distances revealed additional details about ligand-specific pathways contributing to AGTR2 activation and signal propagation. In addition, Dynamic Residue Interaction Network (DRIN) findings, aligned with micro-switch motif analyses, revealed that ligand binding impacts conserved regions, advancing our knowledge of AGTR2 activation mechanisms. These findings highlight the distinct yet complementary roles of Ang II and Ang 1-7 in regulating AGTR2 dynamics, offering new insights into GPCR activation and therapeutic opportunities for cardiovascular diseases. STATEMENT OF SIGNIFICANCE Understanding the intricate molecular mechanisms underlying the activation of G-protein coupled receptors (GPCRs), such as the Angiotensin II type-2 receptor (AGTR2), is vital for advancing therapeutic approaches targeting cardiovascular diseases. This study reveals that both Ang II and Ang 1-7 ligands stably bind to inactive and active-state AGTR2 structures throughout 1 microsecond (μs) long-timescale molecular dynamics (MD) simulations, influencing receptor dynamics and activation mechanisms within the protective arm of the Renin-Angiotensin System (RAS). While both ligands contribute to the stabilization of active-state conformations, Ang II demonstrates a more pronounced effect, potentially prolonging the receptor’s active state and enhancing intracellular signaling. These findings provide critical insights into the functional role of AGTR2 in RAS regulation and highlight its potential as a therapeutic target for conditions such as hypertension and other cardiovascular pathologies.

  • Effects of Angiotensin 1-7 Binding on the Dynamics of Human MAS Proto-Oncogene, GPCR: A Molecular Dynamics Study

    by Ekrem Yasar, M. Murat Yasar, Segun Dogru, Nazmi Yaras, Erol Eroglu

    The understanding of the connections between Angiotensin peptides with the receptors in the Renin-angiotensin system (RAS) is not clear yet. The ACE2/Ang (1-7)/MAS axis, commonly referred to as the protective arm of the RAS, plays a crucial role in maintaining homeostasis within the cardiovascular system. Angiotensin 1-7 (Ang 1-7) is a heptapeptide an integral part of the protective arm of RAS and acts as a ligand binding to the MAS receptor. Understanding the signaling system of the ACE2/Ang (1-7)/MAS axis, which occupies an important place in the RAS, can be considered a serious putative target for the development of new cardiovascular and cancer drugs. It is very important to understand whether the Ang (1-7) ligand binds stably to MAS and, if so, how this affects the dynamics of the receptor. Therefore, we investigated how Ang (1-7) binding affects the stability and communication of the MAS receptor by utilizing molecular dynamics (MD) simulations and various computational techniques. Results indicated that Ang (1-7) was stably bonded to the MAS receptor over the 300[ ]ns simulation period. It was also observed that ligand binding caused a reduction in the fluctuations of the MAS residues. Major changes include a reduction in flexibility of the N-terminal domain, ICL1, ECL1, ECL2, ECL3, TM6 and C-terminal domain residues. Our findings presented in this study may provide a contribution to future studies seeking to gain a deeper understanding of the role of Ang (1-7) interaction with the MAS receptor in the RAS.


  • Open Access

    An in silico investigation of allosteric inhibition potential of Dihydroergotamine against Sars-CoV-2 Main Protease (MPro)

    by Mehmet Murat Yaşar, Ekrem Yaşar, Nuri Yorulmaz, Emin Tenekeci̇, İsmail Hakkı SARPÜN, Erol Eroğlu

    Possible allosteric inhibitors of MPro were investigated using in silico methods. To this end, FDA-approved drugs in the DrugBank database were subjected to virtual screening, and drugs that strongly bind distant from the catalytic site of MPro were identified using molecular docking. Among the identified drugs, Dihydroergotamine (DHE) was chosen for further investigation due to its highest binding score against MPro in the molecular docking experiment. The allosteric inhibition potential of DHE toward MPro was demonstrated by applying some computational tools on the trajectory files which were obtained from the Molecular Dynamics Simulations. Results support that the hydrogen bonding interactions of DHE with GLU278 and THR280, located between Protomer A and Protomer B, affect the structure of the side chain of CYS145 at the catalytic site of MPro. Considering the role of CYS145 in the catalytic cycle, this structural change is likely to be a mechanism for inhibiting MPro.


  • DFT-Based QSAR Modelling of Inhibitory Activity of Coumarins and Sulfocoumarins on Carbonic Anhydrase (CA) Isoforms (CA I and CA II)

    by Erol Eroglu

    Objective: We present three robust, validated and statistically significant quantitative structure-activity relationship (QSAR) models, which deal with the calculated molecular descriptors and experimental inhibition constant (Ki) of 42 coumarin and sulfocoumarin derivatives measured against CA I and II isoforms. Methods: The compounds were subjected to DFT calculations in order to obtain quantum chemical molecular descriptors. Multiple linear regression algorithms were applied to construct QSAR models. Separation of the compounds into training and test sets was accomplished using Kennard-Stone algorithm. Leverage approach was applied to determine Applicability Domain (AD) of the obtained models. Results: Three models were developed. The first model, CAI_model1 comprises 30/11 training/test compounds with the statistical parameters of R2=0.85, Q2=0.77, F=27.57, R2 (test) =0.72. The second one, CAII_model2 comprises 30/12 training/test compounds with the statistical parameters of R2=0.86, Q2=0.78, F=30.27, R2 (test) =0.85. The final model, ΔpKi_model3 consists of 25/3 training/ test compounds with the statistical parameters of R2=0.78, Q2=0.62, F=13.80 and R2(test) =0.99. Conclusion: Interpretation of reactivity-related descriptors such as HOMO-1 and LUMO energies and visual inspection of their maps of orbital electron density leads to a conclusion that the binding free energy of the entire binding process may be modulated by the kinetics of the hydrolyzing step of coumarins.


  • Open Access

    A QSPR Study for the Prediction of the pKa of N-Base Ligands and Formation Constant Kc of Bis(2,2′-bipyridine)Platinum(II)-N-Base Adducts Using Quantum Mechanically Derived Descriptors

    by Selami Palaz, Baki Türkkan, Erol Eroğlu

    Quantitative structure-property relationship (QSPR) study on the acid dissociation constant, pKa of various 22 N-base ligands including pyridines, pyrimidines, purines, and quinolines has been carried out using Codessa Pro methodology and software. In addition, the formation constant, Kc of these ligands with Pt(II)(bpy)2 2+ (bpy = 2,2′-bipyridine) ion has also been modelled with the same methodology. Linear regression QSPR models of pKa and Kc were established with descriptors derived from AM1 calculations. Among the obtained QSPR models of pKa presented in the study, statistically the most significant one is a four parameters linear equation with the squared correlation coefficient, R2 values of ca. 0.95 and the squared cross-validated correlation coefficient, Rcv2 values of ca. 0.89, and external the squared correlation coefficient, Rext.2 values of ca. 0.97. Statistically the most significant QSPR model of Kc is also a four parameters linear equation with the squared correlation coefficient, R2 values of ca. 0.75 and the squared cross-validated correlation coefficient, Rcv2 values of ca. 0.55, and external the squared correlation coefficient, Rext.2 values of ca. 0.81. An analysis of descriptors that involved in the pKa models indicate that reactivity index and charge distribution related descriptors play major roles to model acid dissociation constant of ligands of N bases.